Obesity care is undergoing a dramatic transformation, and nowhere is this more visible than in the pace of change sweeping through the pharmaceutical pipeline. From oral incretin therapies to next-generation dual agonists, the industry is racing to meet a patient population that continues to expand year after year.
Weight Loss Market Size and the Bigger Picture
The Weight Loss Market Size...
Type 2 Diabetes is a chronic, progressive metabolic disorder characterized by insulin resistance and inadequate insulin secretion, resulting in persistently elevated blood glucose and a heightened risk of microvascular and macrovascular complications. Unlike type 1 diabetes, which stems from autoimmune destruction of insulin-producing cells, type 2 diabetes arises from impaired insulin action...
Persistent and recurring pain conditions continue to place a heavy burden on healthcare systems across the 7MM (the US, EU4, the UK, and Japan). Valued at nearly USD 12 billion in 2025, the chronic pain market is forecast to grow at a CAGR of 5.1% through 2036, fueled by an aging population, rising diagnosis rates, and the entry of next-generation therapies. As treatment options diversify, the...
Across the seven major markets (7MM) — the US, EU4 (Germany, France, Italy, Spain), the UK, and Japan — the chronic kidney disease market size was valued at approximately USD 5 billion in 2025 and is projected to keep expanding through 2036. Today's landscape is built on erythropoietin stimulating agents, ACE inhibitors, ARBs, antidiabetic drugs, secondary hyperparathyroidism...
Netherton syndrome is a rare, severe genetic skin disorder that affects newborns and children, often leaving them with fragile, inflamed skin and a lifelong vulnerability to infection. Because it is so uncommon, many families and even clinicians encounter it for the first time only after a difficult diagnostic journey. This article offers a netherton syndrome overview, walks through inheritance...
Progeria is a group of ultra-rare genetic disorders marked by dramatically accelerated aging, and interest in the disease has grown alongside rising diagnostic awareness and expanding research investment. Although the patient population remains extremely small, the progeria drug market continues to attract pharmaceutical players due to advances in genomics, precision medicine, and orphan-drug...
Extracellular vesicles have moved from lab curiosity to a genuine drug-development category. The exosomes market now spans oncology, neurology, dermatology, and regenerative medicine, with the current forecast window running 2025 through 2034 across the US, EU4 (Germany, France, Italy, Spain), the UK, and Japan — even though not a single exosome-based therapy has secured full approval...
Oncology investors and drug developers alike are keeping a close eye on the NSCLC therapeutics market, as non-small cell lung cancer (NSCLC) — responsible for roughly 85% of all lung cancer diagnoses — continues to shift from conventional chemotherapy toward biomarker-guided and immune-based treatment. This transformation is reshaping the lung cancer market at large and cementing...
The Peanut Allergy Treatment landscape has moved well past the days when strict avoidance was the only option available to patients and families. Millions of children and adults live with peanut allergy, a condition that can trigger anaphylaxis from even trace exposure. For decades, management meant vigilance, epinephrine auto-injectors, and constant label-reading. Today, the Peanut Allergy...
Advanced mechanical circulatory support is reshaping how the world treats end-stage heart failure, and the heart pump devices market stands at the center of that shift. Fueled by an aging population, a chronic shortage of transplantable organs, and rapid engineering progress, the global heart pump device market is on track for one of the strongest growth trajectories in the broader medical...
Healthcare innovation is moving faster than most device makers can build factories for, and that gap is exactly why the medical device contract manufacturing industry has become such a critical piece of the medtech supply chain. Rather than investing in dedicated production lines, more OEMs are handing off engineering, molding, and assembly work to specialized partners so they can focus on...
Vision correction after cataract surgery has come a long way, and much of that progress rests on the shoulders of a handful of companies competing fiercely for dominance. The intraocular lens industry has matured into a high-stakes global business, driven by aging populations, rising cataract prevalence, and a steady stream of technological innovation. Understanding who leads this space —...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek